Recordati SpA - Company Profile
Powered by 
All the data and insights you need on Recordati SpA in one report.
$295
- Save hours of research time and resources with
our up-to-date Recordati SpA Strategy Report
- Understand Recordati SpA position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Recordati SpA’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 03 Dec 2021 | Recordati Acquires EUSA Pharma from EW Healthcare Partners | Acquisition |
Recordati SpA
|
EUSA Pharma (UK) Ltd
|
| 29 Jan 2021 | Recordati Enters into Licensing Agreement with Tolmar International | Licensing Agreement |
Recordati SpA
|
Tolmar International Ltd
|
| 06 Nov 2020 | EUSA Pharma (UK) Ltd Enters Phase III Clinical Trial Agreement with Syneos Health Inc for siltuximab (GDCT0392124) | Contract Service Agreement |
EUSA Pharma (UK) Ltd
EUSA Pharma (UK) Ltd
|
Syneos Health Inc Syneos Health Inc |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer